Literature DB >> 12215543

Murine ovarian development is not affected by inactivation of the bcl-2 family member diva.

Helen R Russell1, Youngsoo Lee, Heather L Miller, Jingfeng Zhao, Peter J McKinnon.   

Abstract

Diva (also called Boo/Bcl-B) is a member of the Bcl-2 gene family and most likely functions during apoptosis. Diva is highly expressed in the ovary, and both pro- and antiapoptotic functions have been ascribed to this protein. To determine the role of Diva during murine development, we used gene targeting to inactivate DIVA: The Diva-null mice are born at the expected ratios, are fertile, and have no obvious histological abnormalities, and long-term survival did not differ from littermate controls. Additionally, Diva was not required for apoptosis occurring from genotoxic insult in the ovaries or other organs. Thus, Diva is not critical for the normal development of the ovaries, or in its absence its function is subserved by another protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215543      PMCID: PMC134027          DOI: 10.1128/MCB.22.19.6866-6870.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

Review 1.  BH3-Only proteins-essential initiators of apoptotic cell death.

Authors:  D C Huang; A Strasser
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 2.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

3.  Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak.

Authors:  N Ke; A Godzik; J C Reed
Journal:  J Biol Chem       Date:  2001-02-21       Impact factor: 5.157

4.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

Review 5.  Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm.

Authors:  S Y Hsu; A J Hsueh
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

6.  BCL-2 gene family and the regulation of programmed cell death.

Authors:  S J Korsmeyer
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

Review 7.  Mutations in apoptosis genes: a pathogenetic factor for human disease.

Authors:  L Müllauer; P Gruber; D Sebinger; J Buch; S Wohlfart; A Chott
Journal:  Mutat Res       Date:  2001-07       Impact factor: 2.433

Review 8.  The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control.

Authors:  A Strasser; H Puthalakath; P Bouillet; D C Huang; L O'Connor; L A O'Reilly; L Cullen; S Cory; J M Adams
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

9.  Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons.

Authors:  S P Cregan; J G MacLaurin; C G Craig; G S Robertson; D W Nicholson; D S Park; R S Slack
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 10.  Mouse models of cell death.

Authors:  A M Ranger; B A Malynn; S J Korsmeyer
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

View more
  11 in total

Review 1.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

Review 2.  Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.

Authors:  Maja Sochalska; Selma Tuzlak; Alexander Egle; Andreas Villunger
Journal:  FEBS J       Date:  2015-01-23       Impact factor: 5.542

Review 3.  What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?

Authors:  Kerstin Brinkmann; Ashley P Ng; Carolyn A de Graaf; Andreas Strasser
Journal:  Cell Death Differ       Date:  2022-04-06       Impact factor: 12.067

Review 4.  Bcl-2-family proteins and hematologic malignancies: history and future prospects.

Authors:  John C Reed
Journal:  Blood       Date:  2008-04-01       Impact factor: 22.113

5.  Characterization of the anti-apoptotic mechanism of Bcl-B.

Authors:  Dayong Zhai; Ning Ke; Haichao Zhang; Uri Ladror; Mary Joseph; Andreas Eichinger; Adam Godzik; Shi-Chung Ng; John C Reed
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

6.  Oocytes and early embryos selectively express the survival factor BCL2L10.

Authors:  Yannis Guillemin; Philippe Lalle; Germain Gillet; Jean-François Guerin; Samir Hamamah; Abdel Aouacheria
Journal:  J Mol Med (Berl)       Date:  2009-06-24       Impact factor: 4.599

7.  The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist.

Authors:  G J P Rautureau; M Yabal; H Yang; D C S Huang; M Kvansakul; M G Hinds
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

8.  Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression.

Authors:  Richard W E Clarkson; Matthew T Wayland; Jennifer Lee; Tom Freeman; Christine J Watson
Journal:  Breast Cancer Res       Date:  2003-12-18       Impact factor: 6.466

9.  Mcl-1 is a key regulator of the ovarian reserve.

Authors:  S Omari; M Waters; T Naranian; K Kim; A L Perumalsamy; M Chi; E Greenblatt; K H Moley; J T Opferman; A Jurisicova
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  Diva reduces cell death in response to oxidative stress and cytotoxicity.

Authors:  Nicole Suyun Liu; Xiaoli Du; Jia Lu; Bei Ping He
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.